2m 2m 2m 2m 2m 2m 2m
CAN FITE BIO SP ADS (CANF)
NYSE
$3.14+$0.03 (+0.96%)
Price as of Jun 03, 2026 6:08 PM EDT- $7.2MMarket Cap
- -85.86%1-Year Change
- BiotechnologyIndustry
CAN FITE BIO SP ADS (CANF)
$3.14+$0.03 (+0.96%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 405,000 -39.91% | 674,000 -9.29% | 743,000 -8.27% | 810,000 -5.04% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 405,000 -39.91% | 674,000 -9.29% | 743,000 -8.27% | 810,000 -5.04% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | 263,000 N/A | |
Research and Development Expense | -6.7M +16.26% | -5.8M -3.78% | -6.0M -22.93% | -7.8M -21.19% | |
Depreciation and Amortization Expense | 24,000 +242.86% | 7,000 -53.33% | 15,000 +7.14% | 14,000 0.00% | |
Total Operating Expenses | 10.4M +17.62% | 8.8M +197.94% | 3.0M -5.98% | 3.1M -18.26% | |
Operating Profit | -9.9M +22.39% | -8.1M -0.79% | -8.2M -18.83% | -10.1M -21.38% | |
Interest Income | N/A N/A | N/A N/A | 506,000 +127.93% | 222,000 +37.04% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -77,000 N/A | |
Interest Income and Expense and Net | 0 N/A | 0 -100.00% | 506,000 +248.97% | 145,000 -10.49% | |
Total Nonoperating Income and Expense | 122,000 -51.20% | 250,000 -55.44% | 561,000 +828.57% | -77,000 -133.92% | |
Income before Taxes | -9.9M +26.27% | -7.9M +3.22% | -7.6M -24.96% | -10.2M -19.36% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -7.9M +3.22% | -7.6M -24.96% | -10.2M -19.36% | |
Net Income from Continuing Operations Applicable to Common | N/A N/A | -7.9M +3.22% | -7.6M -24.96% | -10.2M -19.36% | |
Basic EPS and Net Income | -5.97 N/A | 0.00 +100.00% | -0.01 0.00% | -0.01 -66.67% | |
Diluted EPS and Net Income | -5.97 N/A | 0.00 +100.00% | -0.01 0.00% | -0.01 -66.67% | |
Basic Weighted Average Shares | 1.6M -99.92% | 2.2B +70.22% | 1.3B +56.71% | 815.7M +47.49% | |
Diluted Weighted Average Shares | 1.6M -99.92% | 2.2B +70.22% | 1.3B +56.71% | 815.7M +47.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.5M +14.57% | 4.8M +12.79% | 4.3M +43.65% | 3.0M -32.16% | |
Short-Term Investments | N/A N/A | 5,000 -73.68% | 19,000 +137.50% | 8,000 -96.62% | |
Cash and Cash Equivalents and Short-Term Investments | 5.5M +14.45% | 4.8M +12.40% | 4.3M +43.90% | 3.0M -35.47% | |
Total Current Assets | 9.4M +5.10% | 9.0M -9.35% | 9.9M +8.20% | 9.2M -54.37% | |
Accumulated Depreciation | N/A N/A | 43,000 -83.65% | 263,000 +6.05% | 248,000 +5.98% | |
Property and Plant and Equipment and Net | 5,000 -81.48% | 27,000 -6.90% | 29,000 -30.95% | 42,000 -10.64% | |
Total Long-Term Assets | 74,000 -46.38% | 138,000 +70.37% | 81,000 -35.71% | 126,000 -31.89% | |
Total Assets | 9.5M +4.32% | 9.1M -8.70% | 10.0M +7.61% | 9.3M -54.16% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 283 -6.29% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.7M +33.09% | 2.1M +1.58% | 2.0M -19.26% | 2.5M -8.35% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.2M -27.02% | 1.6M -5.45% | 1.7M -25.25% | 2.3M -26.49% | |
Total Liabilities | 2.7M +30.58% | 2.1M +3.44% | 2.0M -19.20% | 2.5M -10.17% | |
Retained Earnings | -176.2M +5.91% | -166.4M +4.97% | -158.5M +5.06% | -150.8M +7.23% | |
Total Stockholders Equity | N/A N/A | 5.4M -12.93% | 6.2M +39.60% | 4.5M -68.91% | |
Total Shares Outstanding | 2.6M -99.91% | 3.0B +119.38% | 1.4B +66.70% | 815.7M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -8.9M +17.18% | -7.6M -9.51% | -8.4M -21.86% | -10.8M +9.57% | |
Capital Expenditures | 2,000 -60.00% | 5,000 +150.00% | 2,000 -77.78% | 9,000 -18.18% | |
Cash from Investing Activities | -2,000 -100.13% | 1.5M +200.20% | 498,000 -94.76% | 9.5M +165.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 9.6M +43.70% | 6.7M -26.61% | 9.1M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -2,456.79% +103.67% | -1,206.23% +9.36% | -1,102.96% -11.51% | -1,246.42% -17.21% | |
Return on Assets | N/A N/A | -82.47% +4.10% | -79.22% +15.01% | -68.89% -18.70% | |
Return on Equity | N/A N/A | -134.94% -5.30% | -142.49% +32.04% | -107.91% -12.51% | |
Revenue Growth | -39.91% +329.77% | -9.29% +12.27% | -8.27% +64.09% | -5.04% -142.74% | |
Current Ratio | 3.46 -21.03% | 4.38 -10.76% | 4.91 +34.02% | 3.66 -50.21% | |
Cash Ratio | 2.02 -13.92% | 2.35 +11.03% | 2.12 +77.94% | 1.19 -25.99% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow